[{"address1": "Bahnhofstrasse 7", "city": "Zug", "zip": "6300", "country": "Switzerland", "phone": "41 41 711 9325", "website": "https://oculis.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases. The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis. The company is based in Zug, Switzerland.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Dr. Riad  Sherif M.B.A., M.D.", "age": 56, "title": "CEO & Director", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sylvia  Cheung", "age": 49, "title": "Chief Financial Officer", "yearBorn": 1975, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gudrun  Bachmann Ph.D.", "title": "Chief Technology Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ramin  Tadayoni M.D., Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel S. Char J.D.", "age": 63, "title": "Chief Legal Officer", "yearBorn": 1961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Virginia R. Dean", "age": 57, "title": "Chief Human Resources Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. P\u00e1ll Ragnar J\u00f3hannesson", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rebecca  Weil", "title": "Chief Commercial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Snehal  Shah Pharm.D.", "title": "President of Research & Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sharon  Klier M.D., M.P.H.", "title": "Chief Development Officer", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 19.64, "open": 19.2, "dayLow": 19.2, "dayHigh": 19.8275, "regularMarketPreviousClose": 19.64, "regularMarketOpen": 19.2, "regularMarketDayLow": 19.2, "regularMarketDayHigh": 19.8275, "payoutRatio": 0.0, "beta": 0.051, "forwardPE": -8.736607, "volume": 51945, "regularMarketVolume": 51945, "averageVolume": 75123, "averageVolume10days": 45830, "averageDailyVolume10Day": 45830, "bid": 14.14, "ask": 25.22, "bidSize": 2, "askSize": 2, "marketCap": 939360000, "fiftyTwoWeekLow": 10.55, "fiftyTwoWeekHigh": 23.08, "priceToSalesTrailing12Months": 1369.3295, "fiftyDayAverage": 20.8556, "twoHundredDayAverage": 15.43698, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 938625216, "profitMargins": 0.0, "floatShares": 44886198, "sharesOutstanding": 48000000, "sharesShort": 24987, "sharesShortPriorMonth": 12814, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0005, "heldPercentInsiders": 0.07039, "heldPercentInstitutions": 0.3104, "shortRatio": 0.43, "shortPercentOfFloat": 0.00059999997, "impliedSharesOutstanding": 49362400, "bookValue": 1.681, "priceToBook": 11.64188, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -85777000, "trailingEps": -2.42, "forwardEps": -2.24, "enterpriseToRevenue": 1368.258, "enterpriseToEbitda": -12.894, "52WeekChange": 0.6726496, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 19.57, "targetHighPrice": 41.025497, "targetLowPrice": 22.056658, "targetMeanPrice": 31.996761, "targetMedianPrice": 32.019264, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 98663000, "totalCashPerShare": 1.864, "ebitda": -72798000, "totalDebt": 1180000, "quickRatio": 2.248, "currentRatio": 2.371, "totalRevenue": 686000, "debtToEquity": 1.608, "revenuePerShare": 0.017, "returnOnAssets": -0.38987, "returnOnEquity": -1.02659, "grossProfits": -51397000, "freeCashflow": -8057875, "operatingCashflow": -47499000, "revenueGrowth": -0.984, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -5753.333, "financialCurrency": "CHF", "symbol": "OCS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -0.35641393, "regularMarketPrice": 19.57, "exchange": "NGM", "messageBoardId": "finmb_589165623", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-03-03", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "postMarketTime": 1742593964, "regularMarketTime": 1742587201, "corporateActions": [], "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1621344600000, "postMarketChangePercent": -1.99284, "postMarketPrice": 19.18, "postMarketChange": -0.389999, "regularMarketChange": -0.069999695, "regularMarketDayRange": "19.2 - 19.8275", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 75123, "fiftyTwoWeekLowChange": 9.0199995, "fiftyTwoWeekLowChangePercent": 0.85497624, "fiftyTwoWeekRange": "10.55 - 23.08", "fiftyTwoWeekHighChange": -3.5100002, "fiftyTwoWeekHighChangePercent": -0.15207973, "fiftyTwoWeekChangePercent": 67.26496, "earningsTimestamp": 1741770000, "earningsTimestampStart": 1741770000, "earningsTimestampEnd": 1741770000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.42, "epsForward": -2.24, "epsCurrentYear": -1.69951, "priceEpsCurrentYear": -11.515083, "fiftyDayAverageChange": -1.2856007, "fiftyDayAverageChangePercent": -0.06164295, "twoHundredDayAverageChange": 4.1330194, "twoHundredDayAverageChangePercent": 0.26773497, "shortName": "Oculis Holding AG", "longName": "Oculis Holding AG", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]